Serge Belanger
Stock Analyst at Needham
(4.57)
# 201
Out of 5,182 analysts
405
Total ratings
54.59%
Success rate
21.87%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Serge Belanger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRDN Viridian Therapeutics | Maintains: Buy | $42 → $32 | $18.84 | +69.85% | 21 | Mar 30, 2026 | |
| KALV KalVista Pharmaceuticals | Maintains: Buy | $35 → $36 | $19.90 | +80.90% | 25 | Mar 25, 2026 | |
| COLL Collegium Pharmaceutical | Reiterates: Buy | $54 → $56 | $32.31 | +73.32% | 29 | Mar 19, 2026 | |
| TRVI Trevi Therapeutics | Maintains: Buy | $22 → $24 | $11.94 | +101.01% | 23 | Mar 18, 2026 | |
| XENE Xenon Pharmaceuticals | Maintains: Buy | $58 → $80 | $56.85 | +40.72% | 15 | Mar 9, 2026 | |
| CRMD CorMedix | Maintains: Buy | $15 → $14 | $7.05 | +98.58% | 21 | Mar 5, 2026 | |
| LQDA Liquidia | Maintains: Buy | $52 → $54 | $37.68 | +43.31% | 36 | Mar 5, 2026 | |
| OCS Oculis Holding AG | Maintains: Buy | $36 → $40 | $26.56 | +50.60% | 3 | Mar 4, 2026 | |
| ESPR Esperion Therapeutics | Maintains: Buy | $4 → $5 | $2.61 | +91.57% | 21 | Mar 3, 2026 | |
| AMPH Amphastar Pharmaceuticals | Maintains: Buy | $34 → $30 | $20.45 | +46.70% | 9 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $36 | $23.63 | +52.35% | 25 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $17.36 | +44.01% | 16 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $85 | $66.73 | +27.38% | 27 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $8.49 | +112.01% | 7 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $48 | $32.99 | +45.50% | 11 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 | $22.70 | +32.16% | 29 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $4.03 | - | 17 | Dec 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $9.02 | +99.56% | 18 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $10.90 | - | 9 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $0.80 | +275.38% | 23 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $5.47 | - | 19 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.38 | - | 1 | Mar 31, 2022 |
Viridian Therapeutics
Mar 30, 2026
Maintains: Buy
Price Target: $42 → $32
Current: $18.84
Upside: +69.85%
KalVista Pharmaceuticals
Mar 25, 2026
Maintains: Buy
Price Target: $35 → $36
Current: $19.90
Upside: +80.90%
Collegium Pharmaceutical
Mar 19, 2026
Reiterates: Buy
Price Target: $54 → $56
Current: $32.31
Upside: +73.32%
Trevi Therapeutics
Mar 18, 2026
Maintains: Buy
Price Target: $22 → $24
Current: $11.94
Upside: +101.01%
Xenon Pharmaceuticals
Mar 9, 2026
Maintains: Buy
Price Target: $58 → $80
Current: $56.85
Upside: +40.72%
CorMedix
Mar 5, 2026
Maintains: Buy
Price Target: $15 → $14
Current: $7.05
Upside: +98.58%
Liquidia
Mar 5, 2026
Maintains: Buy
Price Target: $52 → $54
Current: $37.68
Upside: +43.31%
Oculis Holding AG
Mar 4, 2026
Maintains: Buy
Price Target: $36 → $40
Current: $26.56
Upside: +50.60%
Esperion Therapeutics
Mar 3, 2026
Maintains: Buy
Price Target: $4 → $5
Current: $2.61
Upside: +91.57%
Amphastar Pharmaceuticals
Feb 27, 2026
Maintains: Buy
Price Target: $34 → $30
Current: $20.45
Upside: +46.70%
Feb 26, 2026
Maintains: Buy
Price Target: $31 → $36
Current: $23.63
Upside: +52.35%
Feb 26, 2026
Reiterates: Buy
Price Target: $25
Current: $17.36
Upside: +44.01%
Feb 25, 2026
Maintains: Buy
Price Target: $84 → $85
Current: $66.73
Upside: +27.38%
Feb 20, 2026
Maintains: Buy
Price Target: $20 → $18
Current: $8.49
Upside: +112.01%
Feb 18, 2026
Maintains: Buy
Price Target: $46 → $48
Current: $32.99
Upside: +45.50%
Jan 9, 2026
Maintains: Buy
Price Target: $30
Current: $22.70
Upside: +32.16%
Dec 24, 2025
Reiterates: Hold
Price Target: n/a
Current: $4.03
Upside: -
Nov 4, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $9.02
Upside: +99.56%
Oct 15, 2025
Reiterates: Hold
Price Target: n/a
Current: $10.90
Upside: -
Aug 8, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $0.80
Upside: +275.38%
May 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $5.47
Upside: -
Mar 31, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.38
Upside: -